Genotype-phenotype variability of retinal manifestation in primary hyperoxaluria type 1
- PMID: 29244539
- DOI: 10.1080/13816810.2017.1413660
Genotype-phenotype variability of retinal manifestation in primary hyperoxaluria type 1
Abstract
Background: Primary hyperoxaluria type 1 (PH1) is a rare congenital metabolic disorder of the glyoxylate pathway, which manifests with nephrocalcinosis, urolithiasis, and end-stage renal failure (ESRD) as well as deposition of oxalate crystals within ocular tissues. This report demonstrates classical ocular features of PH1 of the posterior pole and furthermore highlights the ocular genotype-phenotype variability among siblings with identical compound heterozygous alanine-glyoxylate aminotransferase (AGXT) mutations.
Materials and methods: Two siblings, an 8-year-old boy and an 18-year-old girl, with genetically confirmed AGXT mutation (c.364C>T (p.R122X) and c.33dupC), but different renal phenotype underwent an ophthalmic examination, including slit-lamp examination and funduscopy as well as optical coherence tomography (OCT), near-infrared autofluorescence (NIA), and microperimetry examination.
Results: The 8-year-old boy presented with a best-corrected visual acuity (BCVA) of 20/630. Fundus examination revealed bilateral, whitish oxalate deposits and prominent fibrotic macular scars. OCT imaging illustrated hyperdense deposits in all retinal layers and the choroid and the vitreous body along with a prominent dome-shaped macular fibrosis. NIA imaging outlined macular retinal pigment epithelium (RPE) atrophy with panretinal hyperreflective material. Bilateral symptomatic epiphora was putatively due to bilateral depositions of palpable nodular oxalate deposits at the level of the lacrimal sac. In contrary, the 18-year-old sister presented without any signs of ocular oxalate deposition and a BCVA of 20/20.
Conclusions: PH1 is potentially accompanied with a considerable decline in visual acuity due to macular scaring and fibrosis, whereas a profound variability of ocular manifestations can be observed in PH1 patients with identical genotypes.
Keywords: oxalate maculopathy; primary hyperoxaluriatype type; retinal oxalosis.
Similar articles
-
DETAILED CLINICAL PHENOTYPING OF OXALATE MACULOPATHY IN PRIMARY HYPEROXALURIA TYPE 1 AND REVIEW OF THE LITERATURE.Retina. 2016 Nov;36(11):2227-2235. doi: 10.1097/IAE.0000000000001058. Retina. 2016. PMID: 27135212 Review.
-
The Ocular Phenotype in Primary Hyperoxaluria Type 1.Am J Ophthalmol. 2019 Oct;206:184-191. doi: 10.1016/j.ajo.2019.04.036. Epub 2019 May 10. Am J Ophthalmol. 2019. PMID: 31078535
-
The retinal phenotype in primary hyperoxaluria type 2 and 3.Pediatr Nephrol. 2023 May;38(5):1485-1490. doi: 10.1007/s00467-022-05765-1. Epub 2022 Oct 19. Pediatr Nephrol. 2023. PMID: 36260161 Free PMC article.
-
Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center.Nephrol Ther. 2017 May;13(3):176-182. doi: 10.1016/j.nephro.2016.08.002. Epub 2017 Feb 1. Nephrol Ther. 2017. PMID: 28161266 Free PMC article.
-
[Clinical analysis of seven cases with primary hyperoxaluria type 1 in children].Zhonghua Er Ke Za Zhi. 2020 Feb 2;58(2):129-134. doi: 10.3760/cma.j.issn.0578-1310.2020.02.012. Zhonghua Er Ke Za Zhi. 2020. PMID: 32102150 Review. Chinese.
Cited by
-
Reduced Electroretinogram Responses in Morphologically Normal Retina in Patients with Primary Hyperoxaluria Type 1.Ophthalmol Sci. 2023 Jan 2;3(2):100268. doi: 10.1016/j.xops.2022.100268. eCollection 2023 Jun. Ophthalmol Sci. 2023. PMID: 36909147 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical